TrialEpilepsia2022

Fenfluramine significantly reduces day-to-day seizure burden by increasing number of seizure-free days and time between seizures in patients with Dravet syndrome: A time-to-event analysis.

Joseph Sullivan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.